Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
National Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin.
The framework will commence on 1 July 2021 for a period of 18 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Bio Products Laboratory | 07343036 | - | 7 lots 10% Intravenous Immunoglobulin (10% IVIg) - New Business · 5% Intravenous Immunoglobulin (5% IVIg) - New Business · 10% Intravenous Immunoglobulin (10% IVIg) - Existing Business · Subcutaneous Immunoglobulin (SCIg) - New Business · Subcutaneous Immunoglobulin (SCIg) - Existing Business · Anti-D Immunoglobulin (Anti-D) · 5% Intravenous Immunoglobulin (5% IVIg) - Existing Business | LOBBYIST Garnish Hall Enterprises Ltd (1 quarter) |
| Biotest (UK) Ltd | - | - | 4 lots 10% Intravenous Immunoglobulin (10% IVIg) - New Business · 5% Intravenous Immunoglobulin (5% IVIg) - New Business · 10% Intravenous Immunoglobulin (10% IVIg) - Existing Business · 5% Intravenous Immunoglobulin (5% IVIg) - Existing Business | - |
| CSL Behring UK Ltd | 01622483 | - | 5 lots 10% Intravenous Immunoglobulin (10% IVIg) - New Business · 10% Intravenous Immunoglobulin (10% IVIg) - Existing Business · Subcutaneous Immunoglobulin (SCIg) - New Business · Subcutaneous Immunoglobulin (SCIg) - Existing Business · Anti-D Immunoglobulin (Anti-D) | LOBBYIST Burkitt Communications Ltd (1 quarter) |
| Grifols UK Ltd | 01456099 | - | 4 lots 10% Intravenous Immunoglobulin (10% IVIg) - New Business · 5% Intravenous Immunoglobulin (5% IVIg) - New Business · 10% Intravenous Immunoglobulin (10% IVIg) - Existing Business · 5% Intravenous Immunoglobulin (5% IVIg) - Existing Business | - |
| LFB Biopharmaceuticals Ltd | 06058711 | - | 2 lots 10% Intravenous Immunoglobulin (10% IVIg) - New Business · 10% Intravenous Immunoglobulin (10% IVIg) - Existing Business | - |
| Octapharma Ltd | 02372699 | - | 6 lots 10% Intravenous Immunoglobulin (10% IVIg) - New Business · 5% Intravenous Immunoglobulin (5% IVIg) - New Business · 10% Intravenous Immunoglobulin (10% IVIg) - Existing Business · Subcutaneous Immunoglobulin (SCIg) - New Business · Subcutaneous Immunoglobulin (SCIg) - Existing Business · 5% Intravenous Immunoglobulin (5% IVIg) - Existing Business | - |
| Takeda UK Limited | 03362860 | - | 8 lots 10% Intravenous Immunoglobulin (10% IVIg) - New Business · 5% Intravenous Immunoglobulin (5% IVIg) - New Business · 10% Intravenous Immunoglobulin (10% IVIg) - Existing Business · Subcutaneous Immunoglobulin (SCIg) - New Business · Subcutaneous Immunoglobulin (SCIg) - Existing Business · 5% Intravenous Immunoglobulin (5% IVIg) - Existing Business · Facilitated Subcutaneous Immunoglobulin (fSCIg) - Existing Business · Facilitated Subcutaneous Immunoglobulin (fSCIg) - New Business | LOBBYIST Hill & Knowlton Limited (3 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (2 quarters) Burkitt Communications Ltd (1 quarter) Incisive Health Ltd (1 quarter) FORMER MP Sir Kevin Barron— Employment and earnings (former) |
This procurement was divided into 9 lots, each awarded separately. 36 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 2 10% Intravenous Immunoglobulin (10% IVIg) - Existing Business | £1 initial term | 7 | Biotest (UK) Ltd Bio Products Laboratory CSL Behring UK Ltd Grifols UK Ltd LFB Biopharmaceuticals Ltd Octapharma Ltd Takeda UK Limited | complete |
| Lot 3 Subcutaneous Immunoglobulin (SCIg) - Existing Business | £1 initial term | 4 | Bio Products Laboratory CSL Behring UK Ltd Octapharma Ltd Takeda UK Limited | complete |
| Lot 4 Facilitated Subcutaneous Immunoglobulin (fSCIg) - Existing Business | £1 initial term | 1 single bid — no competition | Takeda UK Limited | complete |
| Lot 6 10% Intravenous Immunoglobulin (10% IVIg) - New Business | £1 initial term | 7 | Biotest (UK) Ltd Bio Products Laboratory CSL Behring UK Ltd Grifols UK Ltd LFB Biopharmaceuticals Ltd Octapharma Ltd Takeda UK Limited | complete |
| Lot 7 Subcutaneous Immunoglobulin (SCIg) - New Business | £1 initial term | 4 | Bio Products Laboratory CSL Behring UK Ltd Octapharma Ltd Takeda UK Limited | complete |
| Lot 8 Facilitated Subcutaneous Immunoglobulin (fSCIg) - New Business | £1 initial term | 1 single bid — no competition | Takeda UK Limited | complete |
| Lot 9 Anti-D Immunoglobulin (Anti-D) | £1 initial term | 2 | Bio Products Laboratory CSL Behring UK Ltd | complete |
| Lot 1 5% Intravenous Immunoglobulin (5% IVIg) - Existing Business | £1 initial term | 5 | Octapharma Ltd Takeda UK Limited Biotest (UK) Ltd Grifols UK Ltd Bio Products Laboratory | complete |
| Lot 5 5% Intravenous Immunoglobulin (5% IVIg) - New Business | £1 initial term | 5 | Biotest (UK) Ltd Bio Products Laboratory Grifols UK Ltd Octapharma Ltd Takeda UK Limited | complete |
Government spending data: These suppliers have received £50,696,531 in 1,440 payments (over £25k) from Guy's and St Thomas' NHS FT, East Sussex Healthcare NHS Trust, Manchester University NHS Foundation Trust, Maidstone and Tunbridge Wells NHS Trust, Royal Cornwall Hospitals NHS Trust and 13 more public bodies (2018-04-04 to 2026-03-31).